Description:

CALGB 40601 REGISTRATION WORKSHEET Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=39E131B2-F4E4-13F1-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=39E131B2-F4E4-13F1-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/27/12
  2. 1/9/15
  3. 1/9/15
  4. 9/17/21
Uploaded on:

September 17, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00770809 Registration - CALGB 40601 REGISTRATION WORKSHEET - 2680365v1.0

Details

Endocrine Therapy in Combination with Anti-VEGF Therapy: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy plus for Women with Hormone Receptor-Positive Advanced Breast Cancer

Header Module
Protocol Administration
Patient Demographics/pre-treatment Characteristics
Gender
Race (Mark all that apply)
3 more items in the detailed view.
Ethnicity (Mark one)
Patient Demographics/pre-treatment Characteristics2
Performance Status (ECOG/Zubrod scale)
cm
Kg
Method of Payment (USA only Mark one)
7 more items in the detailed view.
Stage
Certification Of Eligibility And Protocol Design
In the opinion of the investigator, is the patient eligible?
Protocol Design
Stratification factors
Assigned Treatment Arm
Initial Patient Consent For Specimen Use
Patient's Initial Consent given for specimen use for research on the patient's cancer?
Patient's initial consent given for specimen use for genetic research relating to the study treatment
Patient's Initial Consent given for specimen kept for future use in research to learn about, prevent, or treat cancer
Patient's initial consent given for specimen(s) may be kept for use in research to learn about, prevent, or treat other health problems (for example: diabetes, Alzheimer's disease, or heart disease)
Patient's initial consent given for further contact regarding specimen?
Tissue Procurement Kit
Registration Information
Back to the top of the page 

Similar models